Interestingly, we observed increased co-localization of Muc4/Her3 in various stages (10th, 20th and 25th weeks) of pancreatic cancer progression in mice tumor tissues than Muc4/Her2 expression (Figure 2B). The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.